Vaginal Misodel® in Comparison With Orally Administrated Misoprostol (Cytotec®) at Induction of Labour
Launched by KAROLINSKA INSTITUTET · Sep 27, 2016
Trial Information
Current as of June 05, 2025
Unknown status
Keywords
ClinConnect Summary
To compare orally administrated solution of misoprostol (Cytotec®) with vaginal slow release misoprostol (Misodel®) regarding efficacy and safety during labour Design: Randomised controlled trial (RCT)
Settings:
Obstetric departments of Sodersjukhuset, Stockholm Obstetric departments of Women's clinic, Karlstad.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Primipara BS ≤ 4p Gestational week \>37
- Exclusion Criteria:
- • Multipara Multiples Gestational week \<37 BS \>4 IUFD Previous uterine surgery
About Karolinska Institutet
Karolinska Institutet is a renowned medical university located in Sweden, recognized for its commitment to advancing healthcare through innovative research and education. As a leading sponsor of clinical trials, the institution focuses on translating scientific discoveries into effective treatments and therapies, emphasizing patient-centered approaches. With a strong emphasis on collaboration and interdisciplinary research, Karolinska Institutet plays a pivotal role in addressing global health challenges and improving patient outcomes, leveraging its extensive network of experts and state-of-the-art facilities to drive clinical advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Stockholm, , Sweden
Patients applied
Trial Officials
Per Tornvall, Prof
Study Director
Karolinska Institutet
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials